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Introduction {#sec001}
============

HIV and Tuberculosis (TB) are severe global dual-epidemics. Data suggest that co-infection with HIV and *Mycobacterium tuberculosis* (MTB) increases disease progression of both diseases\[[@pone.0118654.ref001]\]. For example, higher HIV viral loads are observed in MTB co-infection and increased HIV replication occurs in MTB infected macrophages \[[@pone.0118654.ref002], [@pone.0118654.ref003]\]. The high levels of inflammation and immune activation, as present in TB, may create an optimal cytokine milieu for HIV replication\[[@pone.0118654.ref004]\]. Whilst immunological impairment is likely to contribute to the increased morbidity and mortality associated with co-infection, the specific mechanisms remain largely unknown. Several studies have reported an impact of HIV on MTB-specific T cell immunity \[[@pone.0118654.ref005],[@pone.0118654.ref006], [@pone.0118654.ref007]\]. For example, increased infection and lysis of MTB-specific T cells has been accredited to HIV infection \[[@pone.0118654.ref005], [@pone.0118654.ref006]\]. Day *et al* showed that HIV infection impairs MTB-specific responses in HIV co-infection with LTBI, demonstrating that the proportion of IL-2 secreting MTB-specific CD4+ T cells inversely correlated with HIV viral load \[[@pone.0118654.ref007]\].

The ability of antigen-specific T cells to simultaneously produce multiple cytokines is believed to correlate with the functional capacity and efficacy of T cells. Frequency of these 'polyfunctional' T cells in blood samples from infected subjects has been associated with clinical control of HIV and TB \[[@pone.0118654.ref008], [@pone.0118654.ref009]\]. For example, higher bacterial load has been shown to decrease MTB-specific T cell functionality and mono-functional T cells have been shown to dominate functionality profiles in TB as compared to LTBI \[[@pone.0118654.ref010]\]. Harari *et al* have reported that greater proportions of TNF-α single-positive CD4 T cells are present in individuals with active TB as compared with LTBI \[[@pone.0118654.ref009]\]. If and how MTB co-infection affects HIV-specific T cell function and polyfunctionality is unknown.

Methods {#sec002}
=======

Participants and Study Samples {#sec003}
------------------------------

We enrolled 13 HIV positive individuals with active TB, 9 HIV positive individuals with latent MTB (LTBI), and 11 HIV positive individuals without evidence of LTBI or active TB ([Table 1](#pone.0118654.t001){ref-type="table"}). All were chronically infected HIV positive South-African adults and were CD4 T cell count matched. Viral loads did not significantly differ between patient groups (p = 0.978). TB was identified by a positive sputum acid-fast bacillus smear or sputum culture. LTBI was defined as a positive ESAT-6/CFP-10 IFN-gamma ELISPOT, in the absence of signs and symptoms of TB \[[@pone.0118654.ref011]\]. Ethical approval and written informed consent from participants was obtained (University of KwaZulu-Natal Biomedical Research Ethics Committee: E028/99 and H020/06). Patients were anti-retroviral treatment naive and not receiving anti-TB treatment.
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###### Viral load and CD4 count information for study participants.

![](pone.0118654.t001){#pone.0118654.t001g}

  HIV+         HIV+/LTBI   HIV+/TB                                                                 
  ------------ ----------- --------- --- ------------ ----- -------- --- ---------- ----- -------- ---
  SK 010 B21   218         5822      F   SK 141 B20   278   2676     F   PID 1079   209   2900     M
  SK 114 B14   274         29100     F   SK 195 B20   207   10077    M   PID 1120   460   3700     M
  SK 139 B20   184         47547     F   SK 236 B9    184   272227   F   PID 1135   253   470000   M
  SK 142 B12   275         186858    F   SK 351 B15   350   285891   F   PID 1224   345   3850     M
  SK 208 B11   126         25523     F   SK 359 B15   466   9449     F   PID 1225   366   224137   M
  SK 212 B22   233         19670     F   SK 364 B15   285   3140     M   PID 821    110   20000    F
  SK 278 B17   443         26036     F   SK 391 B13   247   1936     F   PID 683    195   430000   F
  SK 324 B14   353         144252    F   SK 397 B14   332   198266   M   PID 863    204   49000    M
  SK 373 B15   184         58237     F   SK 425 B13   192   101600   F   PID 917    239   66000    F
  SK 410 B11   495         2570      F                                   PID 929    270   540000   M
  SK 444 B13   331         21447     F                                   PID1024    239   88000    M
                                                                         PID1046    267   17000    M

Flow cytometry {#sec004}
--------------

We assessed T cell functionality using a multi-parameter flow cytometry panel: Viability marker, CD3, CD4, CD8, IFNγ, IL-2, TNF-α, IL-21 and IL-17. Intracellular cytokine staining (ICS) of peripheral blood mononuclear cells (PBMC) was performed following a 6 hour stimulation with either Staphylococcal enterotoxin B (SEB), an HIV Gag peptide pool, or an MTB-specific ESAT-6/CFP-10 peptide pool. FlowJo (version 8.3.3; Treestar) and GraphPad Prism (V.5.5) software were used to analyze the data. A positive antigen-specific response was defined as greater than or equal to 0.05% of the T cell subset analyzed, and 3 times above background.

Statistical analysis {#sec005}
--------------------

GraphPad Prism (V.5.5) was used to perform all statistical analysis. Mann-Whitney test was used to compare continuous outcomes between two groups. For more than two groups comparison, Kruskall-Wallis test with Dunn's post hoc analyses was used. F Fisher's exact test was used to compare categorical outcomes (i.e., pie charts). All *p* values are two sided and a p-value\<0.05 was considered significant.

Results {#sec006}
=======

HIV-specific CD4 T cells were readily detectable in mono-infected individuals ([Fig. 1A and 1B](#pone.0118654.g001){ref-type="fig"}). HIV-specific CD4+ cell release of IFN-γ was significantly lower in HIV+/TB as compared to HIV+/LTBI (p = 0.005)([Fig. 1B](#pone.0118654.g001){ref-type="fig"}). HIV-specific CD4+ cell release of TNF-α (p = 0.01) and IL-2 (p\<0.001) were significantly lower in HIV+/TB as compared to HIV mono-infected individuals. In summary, HIV co-infection with MTB was associated with a decrease in the amount of cytokine (IFN-γ, TNF-α and IL-2) secreted for HIV-specific CD4+ T cells.

![HIV specific CD4+ and CD8+ T cell functionality is reduced in HIV infected individuals co-infected with latent Mycobacterium tuberculosis infection (LTBI) and active Tuberculosis (TB) disease.\
**(A)** Representative flow cytometry plots showing cytokine responses for HIV (gag), control (no antigen) for HIV mono-infected subjects, and subjects co-infected with latent MTB infection (LTBI) and active tuberculosis (TB) **(B)** HIV-specific CD4+ release of IFNγ (p\<0.001), TNFα (p\<0.01) and IL-2 (p\<0.01) were significantly different between all groups (Kruskal-Wallis). **(C)** HIV-specific CD8+ release of IFNγ (p\<0.01) and TNFα (p\<0.001) was significantly lower from HIV mono-infected subjects, to those co-infected with active TB. We additionally assessed the polyfunctionality profile of HIV specific CD4+ and CD8+ T cells in all patient groups. The polyfunctionality profiles between groups differed significantly for both CD4+ (p = 0.04) and CD8+ (p\<0.001).**(D)** HIV-specific CD4+ T cells from HIV mono-infected subjects displayed a polyfunctional CD4+ T cell profile with a maximum of four functions being present (IFN^+^IL-2^+^IL-17^+^TNFα (2%)).**(E)** HIV-specific four function CD4+ T cells were not present in subjects co-infected with LTBI **(F)** Further decreases in HIV-specific CD4+ T cell polyfunctionality were observed in HIV positive subjects co-infected with TB, being replaced by a largely mono-functional profile with a decreased amount of triple cytokine cells (5% as compared to 13% in HIV/LTBI and 15% in HIV mono-infection). Additionally, single positive TNF-α cells dominated the profile (48%). **(G)** HIV-specific CD8+ T cells in HIV mono-infected subjects displayed a polyfunctional profile with a maximum of 2 functions being present (IFN^+^ TNFα (2%). **(H)** A maximum of 2 functions (IFN^+^TNFα^+^ (28%)) were present in HIV-specific CD8+ cells from subjects co-infected with LTBI. **(I)** 87% mono-functional cells were present in the HIV-specific CD8+T cell profile from subjects co-infected with TB, suggesting a complete loss of polyfunctionality.](pone.0118654.g001){#pone.0118654.g001}

HIV-specific CD8+ release of IFN-γ (p\<0.001) and TNFα (p = 0.004) were significantly lower in HIV/TB co-infected subjects as compared to HIV mono-infected subjects ([Fig. 1C](#pone.0118654.g001){ref-type="fig"}). Additionally, IFN-γ secretion was found to be significantly lower in the HIV+/TB group as compared to the HIV+/LTBI group (p = 0.02). No significant antigen-specific production of IL-2, IL-17 or IL-21 was observed for CD8+ T cell responses. In summary, HIV co-infection with MTB was associated with a decrease in the amount of cytokine (TNF-α and IFN-γ) secreted for HIV-specific CD8+ T cells.

Significant differences were also observed between the polyfunctionality profiles for CD4+ (p = 0.04) and CD8+ (p\<0.001) T cells ([Fig. 1 D-I](#pone.0118654.g001){ref-type="fig"}). HIV mono-infected subjects displayed a polyfunctional HIV-specific CD4+ T cell profile with a maximum of four functions (IFN-γ^+^IL-2^+^IL-17^+^TNF-α^+^ (2% of HIV-specific CD4+ T cells)([Fig. 1d](#pone.0118654.g001){ref-type="fig"}). 15% of HIV-specific CD4 T cells were able to secrete 3 cytokines simultaneously (IFN-γ^+^IL-2^+^TNF-α^+^), 26% secreted 2 cytokines (IFN-γ^+^TNF-α^+^(15%),IFN-γ^+^IL-2^+^(6%), IL-2^+^IL-21^+^(5%))while 57% were mono-functional (IFN-γ^+^(31%), TNF-α^+^(26%)). HIV-specific four-function CD4+ T cells were not present in those co-infected with LTBI and this was accompanied by a higher proportion of mono-functional T cells: 65%(IFN-γ^+^(29%),TNF-α^+^(36%))([Fig. 1E](#pone.0118654.g001){ref-type="fig"}).Further changes in HIV-specific CD4+ T cell polyfunctionality were observed in HIV positive subjects co-infected with TB, with only 5% being able to co-secrete 3 cytokines (IFN-γ^+^IL-2^+^TNF-α^+^) and 76% with mono-functional secretion capacity (TNF-α only (47%), IL-2 only (2%), or IFN-γ only (26%))([Fig. 1G](#pone.0118654.g001){ref-type="fig"}). In summary, HIV co-infection with MTB was associated with a decrease in the number of cytokines secreted from HIV-specific CD4+ T cells.

In HIV mono-infected individuals the HIV-specific CD8+ T cell profile consisted of dual cytokine secreting cells IFN-γ^+^TNF-α^+^ (38% of total HIV-specific CD8+ T cells) and mono-functional cells (62% of total HIV-specific CD8+ T cells)([Fig. 1G](#pone.0118654.g001){ref-type="fig"}).Bi-functional T cells were found to be present at progressively lower frequencies from HIV mono-infection, to co-infection with LTBI, to co-infection with TB ([Fig. 1 G-1](#pone.0118654.g001){ref-type="fig"}). 87% mono-functional HIV-specific CD8+ T cells were present in subjects co-infected with TB ([Fig. 1I](#pone.0118654.g001){ref-type="fig"}). In summary, HIV co-infection with MTB was associated with a decrease in the number of cytokines secreted from HIV-specific CD8+ T cells.

Interestingly, when we assessed MTB-specific T cells functionality, we observed a decline in functionality (both in amount and number of cytokines secreted) in HIV-TB co-infected individuals compared to those with HIV-LTBI ([Fig. 2](#pone.0118654.g002){ref-type="fig"}). Mono-functional IFN-γ and TNF-α producing cells dominated the profile of MTB-specific CD8+ cells in HIV infected subjects co-infected with TB (at 78%) ([Fig. 2I](#pone.0118654.g002){ref-type="fig"}).

![MTB-specific CD4+ and CD8+ T cell functionality is reduced in HIV infected individuals co-infected with latent Mycobacterium tuberculosis infection (LTBI) and active tuberculosis (TB) disease.\
**(A)** Representative flow cytometry plots showing cytokine IFN-gamma and TNF-α response for Mycobacterium tuberculosis (MTB) (CFP-10 and ESAT-6). Corresponding negative controls (no antigen) are the same as shown in [Fig. 1B](#pone.0118654.g001){ref-type="fig"}. **(B)** MTB-specific CD4+ release of IFNγ (p = 0.03), TNFα (p\<0.03) and IL-21(p\<0.002) were observed to be significantly lower from subjects co-infected with LTBI to those co-infected with TB. **(C)** MTB-specific CD8+ release of IFNγ (p = 0.022) and TNFα (p\<0.011), were lower subjects co-infected with TB as compared co-infected with LTBI.\
We next assessed the polyfunctionality profile of Mycobacterium tuberculosis (MTB)---specific CD4+ and CD8+ T cells in HIV mono-infection and co-infection with LTBI or TB. **(D).** We observed significant difference between the polyfunctionality profiles of HIV+/LTBI and HIV+/TB groups for both CD4+ (p = 0.007) and CD8+ (p = 0.19). A highly polyfunctional MTB-specific CD4+ T cell cytokine profile was observed in HIV positive subjects co-infected with LTBI, which including the capacity to secrete four cytokines by 12% of MTB-specific T cells (IFN^+^IL-2^+^IL-17^+^TNFα (9%), or IFN^+^IL-21^+^IL-17^+^TNFα (3%)). **(E)** A decrease in the polyfunctional profile of MTB-specific CD4+ T cells was observed in HIV co-infection with TB, with an increased dominance in mono-functional TNFα producing cells (from 12% to 31%). **(F)** MTB-specific CD8+ T cells from HIV infected subjects co-infected with LTBI displayed a profile with a maximum of 2 functions being present (IFN^+^TNFα (41%)). **(G)** Mono-functional IFNγ and TNFα producing cells dominated the profile of MTB-specific CD8+ cells in HIV infected subjects co-infected with TB (at 78%). There was total loss of IL-2 function but IFNγ^+^TNF^+^ double positive cells were present (IFN^+^TNFα^+^ (22%)). An increased dominance in mono-functional TNFα producing cells was also observed (47%).](pone.0118654.g002){#pone.0118654.g002}

We additionally assessed non-specific cytokine production following SEB stimulation ([Fig. 3A-I](#pone.0118654.g003){ref-type="fig"}). Whilst no significant quantitative differences were observed, HIV/TB co-infected subjects appeared to produce less cytokine in response to SEB as compared to HIV/LTBI and HIV mono-infected subjects. Analysis of non-specific CD4+ T cell polyfunctionality revealed a higher quantity in mono-functional cells from HIV mono-infection ([Fig. 3D](#pone.0118654.g003){ref-type="fig"}) to HIV/LTBI ([Fig. 3E](#pone.0118654.g003){ref-type="fig"}) to HIV+/TB ([Fig. 3F](#pone.0118654.g003){ref-type="fig"}). Analysis of non-specific CD8+ T cell polyfunctionality indicated no significant changes between the groups ([Fig. 3G-I](#pone.0118654.g003){ref-type="fig"}).

![Non-specific CD4+ and CD8+ T cell functionality is reduced in HIV infected individuals co-infected with latent Mycobacterium tuberculosis infection (LTBI) and active tuberculosis (TB) disease.\
We assessed non-specific cytokine production following 6 hour SEB stimulation. **(A)** Representative flow cytometry plots showing cytokine responses for SEB stimulated CD4 and CD8 T cells from all patient categories. **(B, C)** No quantitative differences were observed when non-specific cytokine production was compared amongst patient groups. Whilst no significant differences were observed, HIV/TB co-infected subjects appeared to produce less cytokine in response to SEB. **(D, E, F)** Analysis of non-specific CD4 polyfunctionality revealed an increase (p = 0.007) in mono-functional cells from HIV+ mono-infection to HIV/LTBI to HIV/TB. Analysis of non-specific CD8+ T cell polyfunctionality showed no significant difference between the groups (p = 0.19) **(G, H, I)**.](pone.0118654.g003){#pone.0118654.g003}

Discussion {#sec007}
==========

HIV-specific CD4+ and CD8+ T cell functionality was found to be lower in co-infection with LTBI, and to a greater extent TB, as compared to HIV mono-infection. The observed changes in HIV-specific T cell single cytokine release may not necessarily be a loss in functional capacity but rather a loss of HIV-specific T cells. However, the polyfunctionality data are rather striking, showing that MTB co-infection resulted in a reduced ability of HIV-specific T cells to co-secrete multiple cytokines, suggesting that MTB infection augments HIV- specific T cell dysregulation.

In HIV mono-infection, several studies have highlighted the relationship between high-levels of T cell polyfunctionality and the control of HIV disease progression, with increased viral load being linked to a decrease in HIV-specific T cell function \[[@pone.0118654.ref008]\],\[[@pone.0118654.ref012]\]. HIV-specific CD4+ T cells in our HIV mono-infected subjects secreted IFN-y, IL-2, TNF-α, IL-21 and IL-17. The loss of each of these functions individually could have a significant impact on HIV control. For example, IL-21 has been strongly associated with mechanisms of viral control in elite controllers \[[@pone.0118654.ref013]\]. HIV-specific CD8+ T cells in our HIV mono-infected subjects were shown to secrete predominantly TNF-α and IFN-γ withextremely low amounts of IL-2\[[@pone.0118654.ref008]\]. A loss in the ability of CD8+ T cells to produce IL-2 has been shown to be associated with T cell exhaustion \[[@pone.0118654.ref008]\].

For both HIV-specific CD4+ and CD8+ T cells we observed a decline in polyfunctional capacity in MTB co-infection suggesting that mycobacterial load may a role.This is supported by lower MTB-specific T cell functionality in TB co-infection with HIV compared to LTBI. Day *et al*, (2011) have previously demonstrated that the functional capacity (specifically IL-2, TNF-α and IFNγ) of MTB-specific CD4+ T cells is decreased in TB compared to LTBI mono-infection. Our data extend these findings by additionally assessing IL-21 and IL-17 secretion capacity in HIV and MTB co-infection. Our data suggest that the loss of T cell function associated with TB may extend beyond HIV and MTB-specific responses, as our preliminary data reveals impairment in SEB-specific responses in this co-infection state. The high levels of inflammation and immune activation present in TB may enhance general immune exhaustion and T cell anergy \[[@pone.0118654.ref014]\].

Importantly, cytokine T cell profiles may be able to act as biomarkers of specific disease states. Mono-functional TNF-α producing cells dominated the MTB-specific T cell polyfunctionality profiles in those co-infected with TB as compared to those co-infected with LTBI. This confirms and extends the predictive model by Harari *et al* which showed that TNF-α single positive CD4+ T cells can differentiate between LTBI and TB in MTB mono-infected individuals \[[@pone.0118654.ref009]\]. More importantly, we show that this may hold true in HIV co-infection where diagnosing TB is problematic using currently available assays. Mono-functional TNF-α secreting T cells may therefore be an effective diagnostic biomarker for active TB in HIV positive populations. Interestingly, TNF-α generated in response to MTB infection has been shown to increase HIV viral replication suggesting that the cytokine profiles and dominance of TNF-α single producing T cells in TB, may contribute to increased HIV replication and disease progression\[[@pone.0118654.ref015]\]. In addition, our data suggests that the loss of T cell function associated with TB may extend beyond HIV and MTB-specific responses, as our preliminary data revealed impairment in SEB-specific responses in this co-infection state. The high levels of inflammation and immune activation present in TB may enhance general immune exhaustion and T cell anergy \[[@pone.0118654.ref014]\].

In conclusion, our results indicate that MTB infection is linked to lower HIV-specific CD8+ and CD4+ T cell polyfunctionality. As HIV-specific T cells are most defective in HIV co-infection with TB, as compared to LTBI, mycobacterial load may contribute to the loss of T cell function. Decreased T cell function may be a contributing factor to increased HIV disease progression in co-infection as functionally defective HIV-specific T cells may be less able to control HIV.
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